Search results

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

Accommodation Information

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

Successful synthesis of nano-material that improves catalytic converter efficiency.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

ARPANSA has given ANSTO approval to begin testing the neutron reflectometer, Spatz

Every two years the IYNC bring delegates together to discuss various themes within the nuclear industry - this year's being Diversity in Nuclear.

Proposals to Australian Centre for Neutron Scattering and National Deuteration Facility closed

An instrument used to study any materials with structure of the length scale 1-100nm.

Using the theory of compressed sensing technology, a team of physicists and scientists invented and developed the CORIS360® platform imaging technology. Compressed sensing imaging can generate an image with far fewer samples compared with traditional imaging techniques.

ANSTO physicist supports launch of new carbon ion therapy treatment service in Austria.